Table 2 Hospitalisations and bed-days in the French Childhood Cancer Survivor Study (FCCSS) survivors and the reference sample according to the 10th revision of the International Classification of Diseases.
From: Long-term hospitalisations in survivors of paediatric solid tumours in France
Hospitalizations | Bed-days in the hospital | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N° Hospitalizations in FCCSS | Hospitalization rate in FCCSS (per 1000 PY) | N° Hospitalizations in EGB | Hospitalization rate in EGB (per 1000 PY) | AER per 1000 PY | RHR | (95% CI) | N° Bed-Days in FCCSS | Bed-Days rate in FCCS (per 1000 PY) | N° Bed-Days in EGB | Bed-Days rate in EGB (per 1000 PY) | AER per 1000 PY | RBDR | (95% CI) | |
Total | 27,598 | 401.2 | 805,758 | 161.3 | 240.0 | 2.49 | (2.46–2.52) | 74,814 | 1084.4 | 1,555,993 | 311.1 | 773.3 | 3.49 | (3.46–3.51) |
Infections | 245 | 3.6 | 7585 | 1.5 | 2.0 | 2.35 | (2.06–2.66) | 1512 | 21.9 | 35,350 | 7.1 | 14.8 | 3.10 | (2.95–3.26) |
Neoplasms | 10,100 | 146.8 | 205,097 | 41.0 | 105.8 | 3.58 | (3.51–3.65) | 16,156 | 234.2 | 289,619 | 57.9 | 176.3 | 4.04 | (3.98–4.11) |
Haematological | 237 | 3.4 | 5233 | 1.0 | 2.4 | 3.29 | (2.88–3.74) | 858 | 12.4 | 19,169 | 3.8 | 8.6 | 3.24 | (3.03–3.47) |
Endocrine | 830 | 12.1 | 17,153 | 3.4 | 8.6 | 3.51 | (3.28–3.76) | 2185 | 31.7 | 67,426 | 13.5 | 18.2 | 2.35 | (2.25–2.45) |
Mental | 300 | 4.4 | 18,899 | 3.8 | 0.6 | 1.15 | (1.03–1.29) | 782 | 11.3 | 48,923 | 9.8 | 1.6 | 1.16 | (1.08–1.24) |
Neurological | 803 | 11.7 | 23,414 | 4.7 | 7.0 | 2.49 | (2.32–2.67) | 4433 | 64.3 | 55,985 | 11.2 | 53.1 | 5.74 | (5.57–5.91) |
Ocular | 326 | 4.7 | 13,992 | 2.8 | 1.9 | 1.69 | (1.51–1.89) | 453 | 6.6 | 8277 | 1.7 | 4.9 | 3.97 | (3.61–4.35) |
Auditory | 109 | 1.6 | 4311 | 0.9 | 0.7 | 1.84 | (1.51–2.22) | 236 | 3.4 | 6865 | 1.4 | 2.0 | 2.49 | (2.18–2.83) |
Cardiovascular | 1900 | 27.6 | 42,035 | 8.4 | 19.2 | 3.28 | (3.14–3.43) | 9065 | 131.4 | 139,661 | 27.9 | 103.5 | 4.70 | (4.61–4.8) |
Pulmonary | 601 | 8.7 | 20,994 | 4.2 | 4.5 | 2.08 | (1.92–2.25) | 4155 | 60.2 | 84,894 | 17.0 | 43.2 | 3.55 | (3.44–3.66) |
Gastrointestinal | 2113 | 30.7 | 116,056 | 23.2 | 7.5 | 1.32 | (1.27–1.38) | 5901 | 85.5 | 171,616 | 34.3 | 51.2 | 2.49 | (2.43–2.56) |
Skin | 393 | 5.7 | 14,316 | 2.9 | 2.8 | 1.99 | (1.8–2.2) | 872 | 12.6 | 25,460 | 5.1 | 7.5 | 2.48 | (2.32–2.65) |
Musculoskeletal | 881 | 12.8 | 54,634 | 10.9 | 1.9 | 1.17 | (1.1–1.25) | 3317 | 48.1 | 137,421 | 27.5 | 20.6 | 1.75 | (1.69–1.81) |
Genitourinary | 3462 | 50.3 | 79,401 | 15.9 | 34.4 | 3.17 | (3.06–3.27) | 11,259 | 163.2 | 148,360 | 29.7 | 133.5 | 5.50 | (5.4–5.6) |
Congenital Malformations | 153 | 2.2 | 3514 | 0.7 | 1.5 | 3.16 | (2.68–3.71) | 498 | 7.2 | 7390 | 1.5 | 5.7 | 4.88 | (4.47–5.33) |
Symptoms Unclassified | 1160 | 16.9 | 42,017 | 8.4 | 8.5 | 2.01 | (1.89–2.12) | 3108 | 45.0 | 60,888 | 12.2 | 32.9 | 3.70 | (3.57–3.83) |
Injury—Poisoning | 1003 | 14.6 | 53,385 | 10.7 | 3.9 | 1.36 | (1.28–1.45) | 4344 | 63.0 | 136,490 | 27.3 | 35.7 | 2.31 | (2.24–2.38) |
Other Factors | 2982 | 43.4 | 83,722 | 16.8 | 26.6 | 2.59 | (2.5–2.68) | 5680 | 82.3 | 112,199 | 22.4 | 59.9 | 3.67 | (3.57–3.77) |
Total Excluding Neoplasms | 17,498 | 254.4 | 600,661 | 120.2 | 134.2 | 2.12 | (2.08–2.15) | 58,658 | 850.2 | 1,266,374 | 253.2 | 597.0 | 3.36 | (3.33–3.38) |
